J Am Med Dir Assoc
January 2025
Objectives: This research aimed to determine postpartum females' self-reported adherence to and experience with short-term thromboprophylaxis using enoxaparin injection, after counselling by pharmacists. It also sought to assess their knowledge of thromboprophylaxis, injection techniques, and confidence in self-injecting.
Methods: This prospective cohort study was conducted at a public tertiary hospital in Malaysia from March to June 2023.
Background: Chlorate is an effective herbicide, but also a byproduct of chlorinating agents used to disinfect water, which is one of the reasons why it is regularly found in food. Perchlorate is a ubiquitous contaminant, which is naturally occurring in the environment but also released from anthropogenic sources such as the industrial use of certain natural fertilizers. Chlorate affects the hematological system, and perchlorate the thyroid.
View Article and Find Full Text PDFWestern Pac Surveill Response J
February 2023
The newly developed vanadium dioxide (VO), a material with excellent reversible and multi-stimuli responsible phase transition property, has been widely used in high-performance and energy-saving smart devices. The rapid growth of the VO-based emerging technologies and the complex biological effect of vanadium to organisms urge a better understanding of the behavior of VO in vivo for safety purpose. Herein, we study the absorption, distribution, and excretion of two commercial VO (nanoscale SVO and bulk MVO) in mice after consecutive gavage administration for up to 28 days.
View Article and Find Full Text PDFThe rapid development of smart materials stimulates the production of vanadium dioxide (VO) nanomaterials. This significantly increases the population exposure to VO nanomaterials via different pathways, and thus urges us to pay more attentions to their biosafety. Liver is the primary accumulation organ of nanomaterials in vivo, but the knowledge of effects of VO nanomaterials on the liver is extremely lacking.
View Article and Find Full Text PDFBackground: Type 2 diabetes is associated with an increased cardiovascular risk. Use of aspirin has been shown to be of benefit for secondary prevention of cardiovascular disease in patients with type 2 diabetes; benefits in primary prevention have not been clearly proven.
Aims: This study aims to (a) determine if aspirin is prescribed appropriately in type 2 diabetes for primary or secondary prevention of cardiovascular disease (CVD) and (b) evaluate whether there are differences in aspirin prescribing according to where people receive their care.
Aim: To determine epidemiology of Bruneian paediatric chronic kidney disease (CKD) patients and factors that affect growth and progression of disease.
Methods: A cross-sectional study conducted on all children below 18 years old who were diagnosed with CKD over a ten year period (2004 to 2013). The reference population was all children (< 18 years old) suffering from CKD and attending the tertiary paediatric nephrology clinic in Brunei Darussalam.